Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 Study
A pharmacological elevation of GLP-1 is able to restore insulin secretion in type 2 diabetes (6)
Future studies are needed to identify which people with MS are most likely to benefit from taking a GLP-1, the safest dosing strategies, and whether these medications have long-term disease-modifying effects in MS, she says
With increased stability, oral preparations also have extended durations of action, further increasing their therapeutic potential [9, 10, 11, 12]
Without knowing the exact amount in the proprietary blend, you are taking it on faith that Tranont included a therapeutically relevant dose